Resources - TD2 Precision Oncology

Leading the way in defining a new Immunotherapy Response Score (IRS) to predict checkpoint inhibitor benefit - TD2 Precision Oncology

Written by TD2 Admin | Feb 16, 2023 2:23:00 AM